CAMP4 Therapeutics
CAMP | NASDAQ
$3.86
+$0.06 (+1.58%)
At close: Nov 16, 2026, 4:00 PM ET
$3.62
-$0.24 (-6.11%)
After-hours:
Nov 16, 2026, 7:52 PM ET
+1.58%
(1D)No price chart data available for 1D timeframe.
Rating
40.2
+5.4 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #522/1021 (Top 51%)
Key Statistics
Market Data
Market Cap $304.73M
1D Range
3.58 4.05
52W Range
2.90 7.13
Valuation (TTM)
PE -1.88
PB 2.85
EV/EBITDA -2.59
Valuation (NTM)
Forward PE N/A
Forward PEG 0.05
Price Target $9.00
Cash Flow
FCF Yield -8.7%
SBC Adj. FCF Yield -10.8%
SBC Impact -24.9%
Margins
Gross Margin 80.4%
Operating Margin -1556.7%
FCF Margin -771.9%
Growth (CAGR)
Revenue 3Y | 5Y 113.8% |
N/A
Dil EPS 3Y | 5Y 6.7% |
N/A
FCF 3Y | 5Y 25.0% |
N/A
Returns
ROA -90.4%
ROE -261.8%
ROIC -46.0%
Financial Health
Net Cash
$118.07M
Current Ratio 6.42
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and developme...
Sector Healthcare
Industry Biotechnology
Employees 48
IPO Date Oct 11, 2024
Website www.camp4tx.com
Fiscal Year March - February
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.37
Miss -90.94%
YoY:
+32.73% REV
$1.9M
Beat +10.62%
YoY:
+138.87%Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$9.00
Upside
+133.16%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CAMP